AzTrials
AzTrials

Trigger PointsNCT04089228

Kinesio Taping on Trapezius Trigger Points After Integrated Neuromuscular Inhibition Technique (INIT)

A study testing Kinesiotaping and Integrated Neuromuscular Inhibition Technique in people with Trigger Points, run by Riphah International University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this research is to see the effects of kinesio taping after integrated neuromuscular inhibition technique on pain, disability, pain-pressure threshold and muscle length in patients with upper trapezius trigger points. There will be two groups experimental and control. Read more about this study

Who is it for?
Ages 20 to 50 years
Conditions the study is for
Trigger Points
What is being tested?
Kinesiotaping and Integrated Neuromuscular Inhibition Technique
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 sitePakistan
Study dates
1 Feb 2019to 30 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Upper Trapezius Active or latent trigger points
  • Limited range of motion (cervical Side Bending)

Who cannot join

  • Radiculopathies
  • Malignancy
  • Infection
  • Trauma

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Riphah International University

    Islamabad, Federal, Pakistan, 44000

Other trials in Pakistan

About this study

Official title: Effects of Kinesio Taping on Upper Trapezius Trigger Points After Integrated Neuromuscular Inhibition Technique (INIT)

The aim of this research is to see the effects of kinesio taping after integrated neuromuscular inhibition technique on pain, disability, pain-pressure threshold and muscle length in patients with upper trapezius trigger points. There will be two groups experimental and control. One study group will receive kinesiotaping after integrated neuromuscular inhibition technique and the other group will only receive integrated neuromuscular inhibition technique.

Read the detailed description

This study is Randomized controlled trail done at physiotherapy department of Railway General Hospital Rawalpindi. The sample size of 26 individuals calculated using open epi tool. Sampling technique applied was convenience sampling. Randomization in groups by sealed envelope method. The subjects were divided into two groups with 13 patients each. Both groups were treated with Integrated neuromuscular inhibition technique (Muscle energy Technique, sustain pressure, Strain counter-strain) while Kinesio tape was applied after INIT in only experimental group. Study duration was of 6 months. Individuals having age between 20-40 years, upper trapezius active or latent trigger points, limited side bending were included in this study. Tools used in the study were neck disability index (NDI), algometry, numeric pain rating scale (NPRS) and muscle length (side bending through inclinometer). Assessments were taken on 1st day pre and post intervention and on 4th day.

Conditions
Trigger Points
Being tested
Kinesiotaping, Integrated Neuromuscular Inhibition Technique
Keywords
Myofascial trigger points, Kinesiotaping, Integrated Neuromuscular Inhibition Technique

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • KinesiotapingOther

    Total of 4 sessions on upper trapezius trigger points on alternate days.

  • Integrated Neuromuscular Inhibition TechniqueOther

    Sustain Pressure. Strain Counter-strain (for 90 sec) Passive Isometric Relaxation (PIR) (6-10 sec hold, 4 reps)

Study groups in NCT04089228
Study groupRoleWhat they receive
Kinesiotape Group and INITExperimentalKinesiotaping and Integrated Neuromuscular Inhibition Technique (KT + INIT )
Receives: Other: Kinesiotaping; Other: Integrated Neuromuscular Inhibition Technique
INIT GroupActive comparatorIntegrated Neuromuscular Inhibition Technique (INIT)
Receives: Other: Integrated Neuromuscular Inhibition Technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neck disability index

    Changes from the baseline, The NDI is a modification of the neck disability index and it was developed by Vernon and Mior. It was designed to measure the neck pain and disability over time. It consists of 10 items, five parts sections. At the end, score is calculated by dividing the obtained score by total 50 multiplied by 100.

    Measured: 4th Day

  2. Pain-Pressure threshold (PPT)

    Changes from the baseline, Pain-pressure threshold was measured with the help of an algometer.

    Measured: 4th day

  3. NPRS

    Changes from the baseline, Numeric Pain rating scale is a scale for pain intensity starting from 0-10. Where 0 indicates no pain and 10 indicate severe pain.

    Measured: 4th Day

Secondary outcomes (1)
  1. Muscle length measure

    Changes from the baseline, Muscle length of upper trapezius was measured with the help of Inclinometer

    Measured: 4th Day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2019
  2. Study start1 Feb 2019
  3. Primary completion20 Jun 2019
  4. Study completion30 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04089228
Sponsor's protocol ID
RiphahIU Nowal Kamran
Status last verified
Sep 2019
First submitted
4 Sep 2019
Last updated
13 Sep 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Vazquez-Delgado E, Cascos-Romero J, Gay-Escoda C. Myofascial pain syndrome associated with trigger points: a literature review. (I): Epidemiology, clinical treatment and etiopathogeny. Med Oral Patol Oral Cir Bucal. 2009 Oct 1;14(10):e494-8. doi: 10.4317/medoral.14.e494.

    PubMed 19680218
  • Lluch E, Nijs J, De Kooning M, Van Dyck D, Vanderstraeten R, Struyf F, Roussel NA. Prevalence, Incidence, Localization, and Pathophysiology of Myofascial Trigger Points in Patients With Spinal Pain: A Systematic Literature Review. J Manipulative Physiol Ther. 2015 Oct;38(8):587-600. doi: 10.1016/j.jmpt.2015.08.004. Epub 2015 Sep 19.

    PubMed 26387860
  • Lavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Anesthesiol Clin. 2007 Dec;25(4):841-51, vii-iii. doi: 10.1016/j.anclin.2007.07.003.

    PubMed 18054148
  • Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician. 2002 Feb 15;65(4):653-60.

    PubMed 11871683
  • Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome. J Bodyw Mov Ther. 2008 Oct;12(4):371-384. doi: 10.1016/j.jbmt.2008.06.006. Epub 2008 Aug 13.

    PubMed 19083696
  • Cerezo-Tellez E, Torres-Lacomba M, Mayoral-Del Moral O, Sanchez-Sanchez B, Dommerholt J, Gutierrez-Ortega C. Prevalence of Myofascial Pain Syndrome in Chronic Non-Specific Neck Pain: A Population-Based Cross-Sectional Descriptive Study. Pain Med. 2016 Dec;17(12):2369-2377. doi: 10.1093/pm/pnw114. Epub 2016 Jun 20.

    PubMed 28025371
  • Vernon H, Schneider M. Chiropractic management of myofascial trigger points and myofascial pain syndrome: a systematic review of the literature. J Manipulative Physiol Ther. 2009 Jan;32(1):14-24. doi: 10.1016/j.jmpt.2008.06.012.

    PubMed 19121461
  • Bubnov RV. Evidence-based pain management: is the concept of integrative medicine applicable? EPMA J. 2012 Oct 22;3(1):13. doi: 10.1186/1878-5085-3-13.

    PubMed 23088743

Questions about this trial

What is this clinical trial studying?

A study testing Kinesiotaping and Integrated Neuromuscular Inhibition Technique in people with Trigger Points, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neck disability index (time frame: 4th Day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04089228, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in